HEK293 - SLC13A5 (KO) Cell Line
Key Features
Cat. No.:
NTV-0925-YJ1465
Species
Human
Related Disease
Developmental and epileptic encephalopathy 25
Summary
| Description | This product provides a HEK293 cell line in which the SLC13A5 gene has been specifically inactivated. The gene disruption was achieved using CRISPR/Cas9 technology.This meticulous engineering process ensures a reliable cellular model for studying the functional loss of SLC13A5. |
| Species | Human |
| Size | 1×10⁶ cells |
| Growth Conditions | 37°C with 5% CO₂ |
| Related Disease | Developmental and epileptic encephalopathy 25 |
| Synonyms | HEK293 SLC13A5 knockout; SLC13A5-deficient HEK293 cells; HEK293 SLC13A5-null; 293 cells with SLC13A5 gene knockout; SLC13A5 KO HEK293 cells |
| Parental cells | HEK293 |
| Format | Frozen |
| Shipping | Dry Ice |
| Storage | Store in liquid nitrogen. |
Specifications
| Mycoplasma Testing | Negative |
| Cryopreservation Medium | 95% Complete Culture Medium with 5% DMSO |
| Research Use Only | For Research Use Only. Not For Clinical Use. |
Online Inquiry
Datasheet